| and the shorts continue |
| @jev1937 |
06/22/2023 10:03:35 AM |
| Holding long for 300 plus easy money |
| @Lacrom |
06/21/2023 11:02:17 PM |
| $NTLA Price now up |
| @thehydro |
06/21/2023 9:36:40 AM |
| When is this gonna take off? |
| @Stockman |
06/18/2023 8:53:45 PM |
| $NTLA great article |
| @JimmyOneTime |
06/13/2023 10:42:10 PM |
| $NTLA should we be shorting? |
| @erniestools |
06/09/2023 5:30:23 AM |
| $NTLA MomentumIts gaining |
| @securingthebagg |
06/08/2023 5:42:03 PM |
| $NTLA The gaining last trade up |
| @McRose |
06/08/2023 3:08:46 PM |
| $NTLA What do you make of this? |
| @raven |
06/06/2023 1:46:30 PM |
| $NTLA MomentumIts gaining up |
| @asasasas |
06/05/2023 4:28:12 PM |
| MomentumIts now |
| @boysisidro |
05/30/2023 11:31:52 AM |
| Thoughts on where this is headed? |
| @cruzak |
05/30/2023 1:36:24 AM |
| bulls and bears |
| @Disprz |
05/29/2023 11:51:59 PM |
| $NTLA The gaining up |
| @hermanboren |
05/28/2023 8:34:04 PM |
| Price gaining |
| @bclarkassoc |
05/26/2023 5:30:44 PM |
| New preclinical data https://www.globenewswire.com/news-release/2022/05/02/24333 |
| @FFfssdfggg |
05/02/2022 4:06:00 PM |
| Also, https://jitc.bmj.com/content/8/Suppl_3/A103.2 |
| @Huyhuynh9990 |
02/14/2022 1:08:33 AM |
| https://www.fiercebiotech.com/research/engineered-tcr-t-cells-by-fred-hutch-san- |
| @LastCStanding |
02/09/2022 11:18:02 PM |
| ASH abstracts |
| @Ph1lk |
11/04/2021 6:17:49 PM |
| PR https://www.globenewswire.com/news-release/2021/10/20/2317270/0/en/Intellia-T |
| @jfrank2255 |
10/20/2021 7:16:26 PM |
| The company will present new data at the |
| @vizziatech |
10/12/2021 4:42:29 PM |
| The company has announced that it has submitted |
| @Lemarrnathan |
08/05/2021 5:03:06 PM |
| And $BEAM |
| @Bigsurf |
06/30/2021 4:05:40 PM |
| Sudden burst in genomic stocks.$ NTLA,$ EDIT, $CRSP |
| @Br1XXX |
06/30/2021 3:22:23 PM |
| Big gap and lot of money to be |
| @priyankshah |
06/29/2021 11:02:03 AM |
| znewcar1: NTLA 50% v21,8M c133.43 f68,1M H144.4 morning pop and fade |
| @gichisum59 |
06/29/2021 4:09:22 AM |
| You do understand that this is a biotech |
| @Mattyhudz20 |
06/28/2021 9:41:00 PM |
| Large negatives across the board. Revenue Per Share $0.86 |
| @WeappItright |
06/28/2021 3:57:06 PM |
| Blackstone Life Sciences, Cellex Cell Professionals, and Intellia |
| @efrky |
06/24/2021 7:30:19 PM |
| Adding CD8 coreceptors may enhance CD4+ T-cell responses |
| @johnrobertjr001 |
05/01/2021 1:59:09 AM |
| Knock-ins, knockdowns and/or overexpression are other ways to |
| @nicko41 |
05/01/2021 1:50:55 AM |
| In the setting of established and (rapidly) proliferating |
| @ZT21 |
05/01/2021 1:43:58 AM |
| This was presented at SITC last year https://jitc.bmj.com/content/8/Suppl_3/A103 |
| @early_bird |
04/30/2021 8:21:06 PM |
| This trial showed that donor-derived, CD8+ T-cells engineered |
| @ramo1989 |
04/30/2021 8:19:29 PM |
| https://www.businesswire.com/news/home/20210107005234/en/ArsenalBio-Announces-Mu |
| @farml1234 |
01/09/2021 10:49:48 PM |
| Cathie Wood likes some cutting edge Gene editing |
| @Timose |
01/07/2021 3:28:57 PM |
| $NTLA 5001, a T Cell Product Candidate with |
| @Oilers99 |
12/05/2020 6:22:47 PM |
| Arsenal Bio is also using it for |
| @amitchate |
11/25/2020 7:59:16 PM |
| Currently, the company is using CRISPR/Cas9 screening to |
| @ctidwell |
11/25/2020 7:58:37 PM |
| Preclinical data (at ASH) https://ashpublications.org/blood/article/136/Suppleme |
| @Chr |
11/04/2020 11:06:01 PM |
| Bought more at $18.30 before selling all @ |
| @JamonTrades |
01/08/2018 6:50:15 PM |
| CRISPR hits a snag: Our immune systems may |
| @nicnott |
01/08/2018 3:57:51 PM |
| In at $18.90. Got to believe the drop |
| @efrky |
01/08/2018 3:56:50 PM |
| I don't have enough understanding on how the |
| @eamonjobling |
10/09/2017 5:19:13 PM |
| Am I the only one that thinks this |
| @zpeer3 |
10/06/2017 7:38:42 PM |
| Which of the big three is closest to |
| @Jaytrades81 |
03/07/2017 7:18:43 PM |
| Took a starter here, CRISPR could do amazing things! |
| @khirennas |
05/10/2016 3:00:34 PM |